+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Cannabis Pharmaceuticals Market Research Report by Brand (Epidiolex and Sativex), Product Type, Distribution Channel, Application, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • ID: 5313725
  • Report
  • April 2022
  • Region: Global
  • 197 Pages
  • 360iResearch™
UP TO OFF until Dec 31st 2022
The Global Cannabis Pharmaceuticals Market size was estimated at USD 1,031.56 million in 2021, USD 1,222.09 million in 2022, and is projected to grow at a Compound Annual Growth Rate (CAGR) of 18.64% to reach USD 2,877.64 million by 2027.



Market Statistics:


The report provides market sizing and forecast across five major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Cannabis Pharmaceuticals to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Brand, the market was studied across Epidiolex and Sativex.
  • Based on Product Type, the market was studied across Ointments & Creams and Solids and Dissolvable Powder & Oil.
  • Based on Distribution Channel, the market was studied across Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies.
  • Based on Application, the market was studied across Arthritis, Cancer, Epilepsy, and Migraine.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:


We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.

This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Cannabis Pharmaceuticals market considering the current update on the conflict and its global response.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Cannabis Pharmaceuticals Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Cannabis Pharmaceuticals Market, including AbbVie Inc., Amyris, Inc., Aphria, Inc., Aurora Cannabis, Inc., Botanix Pharmaceuticals, Breath of Life Pharma, Ltd., Cannabis Science, Inc., Canopy Growth Corporation, Cara Therapeutics, CB Therapeutics Inc., Corbus Pharmaceuticals Holdings, Inc., Cronos Group Inc., GW Pharmaceuticals, PLC, Insys Therapeutics, Inc., Medical Marijuana Inc., Medicure Pharmaceuticals, MedReleaf Corp., MGC Pharmaceuticals Limited, Pascal Biosciences Inc., PharmaCyte Biotech, Inc., Serina Therapeutics, Inc., Teva Pharmaceutical Industries Ltd., Tilray, Inc., Valeant Pharmaceuticals, and Zynerba Pharmaceuticals, Inc..

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Cannabis Pharmaceuticals Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Cannabis Pharmaceuticals Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Cannabis Pharmaceuticals Market?
4. What is the competitive strategic window for opportunities in the Global Cannabis Pharmaceuticals Market?
5. What are the technology trends and regulatory frameworks in the Global Cannabis Pharmaceuticals Market?
6. What is the market share of the leading vendors in the Global Cannabis Pharmaceuticals Market?
7. What modes and strategic moves are considered suitable for entering the Global Cannabis Pharmaceuticals Market?
Frequently Asked Questions about the Global Cannabis Pharmaceuticals Market

What is the estimated value of the Global Cannabis Pharmaceuticals Market?

The Global Cannabis Pharmaceuticals Market was estimated to be valued at $1031.6 Million in 2021.

What is the growth rate of the Global Cannabis Pharmaceuticals Market?

The growth rate of the Global Cannabis Pharmaceuticals Market is 18.6%, with an estimated value of $2877.6 Million by 2027.

What is the forecasted size of the Global Cannabis Pharmaceuticals Market?

The Global Cannabis Pharmaceuticals Market is estimated to be worth $2877.6 Million by 2027.

Who are the key companies in the Global Cannabis Pharmaceuticals Market?

Key companies in the Global Cannabis Pharmaceuticals Market include AbbVie Inc., Amyris, Inc., Aphria, Inc., Aurora Cannabis, Inc., Botanix Pharmaceuticals, Breath of Life Pharma, Ltd., Cannabis Science, Inc., Canopy Growth Corporation and CB Therapeutics Inc..

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increase in the legalization of medicinal cannabis in economies
5.1.1.2. Growing awareness about the medical benefits of cannabidiol and its remedial properties
5.1.1.3. Growing usage of cannabis-based pharmaceuticals for various indications such as inflammation, chronic pain, sleep disorders, and others
5.1.2. Restraints
5.1.2.1. High price associated with the medical cannabis
5.1.3. Opportunities
5.1.3.1. Rise in investments by pharma companies in CBD and developments for cannabinoid regulation
5.1.3.2. Innovation and launching new products
5.1.4. Challenges
5.1.4.1. Availability of various alternatives in the market
5.2. Cumulative Impact of COVID-19
5.3. Cumulative Impact of 2022 Russia Ukraine Conflict
6. Cannabis Pharmaceuticals Market, by Brand
6.1. Introduction
6.2. Epidiolex
6.3. Sativex
7. Cannabis Pharmaceuticals Market, by Product Type
7.1. Introduction
7.2. Ointments & Creams
7.3. Solids and Dissolvable Powder & Oil
8. Cannabis Pharmaceuticals Market, by Distribution Channel
8.1. Introduction
8.2. Hospital Pharmacies
8.3. Online Pharmacies
8.4. Retail Pharmacies
9. Cannabis Pharmaceuticals Market, by Application
9.1. Introduction
9.2. Arthritis
9.3. Cancer
9.4. Epilepsy
9.5. Migraine
10. Americas Cannabis Pharmaceuticals Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Cannabis Pharmaceuticals Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
12. Europe, Middle East & Africa Cannabis Pharmaceuticals Market
12.1. Introduction
12.2. France
12.3. Germany
12.4. Italy
12.5. Netherlands
12.6. Qatar
12.7. Russia
12.8. Saudi Arabia
12.9. South Africa
12.10. Spain
12.11. United Arab Emirates
12.12. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis
13.3. Market Share Analysis, By Key Player
13.4. Competitive Scenario
13.4.1. Merger & Acquisition
13.4.2. Agreement, Collaboration, & Partnership
13.4.3. New Product Launch & Enhancement
13.4.4. Investment & Funding
13.4.5. Award, Recognition, & Expansion
14. Company Usability Profiles
14.1. AbbVie Inc.
14.2. Amyris, Inc.
14.3. Aphria, Inc.
14.4. Aurora Cannabis, Inc.
14.5. Botanix Pharmaceuticals
14.6. Breath of Life Pharma, Ltd.
14.7. Cannabis Science, Inc.
14.8. Canopy Growth Corporation
14.9. Cara Therapeutics
14.10. CB Therapeutics Inc.
14.11. Corbus Pharmaceuticals Holdings, Inc.
14.12. Cronos Group Inc.
14.13. GW Pharmaceuticals, PLC
14.14. Insys Therapeutics, Inc.
14.15. Medical Marijuana Inc.
14.16. Medicure Pharmaceuticals
14.17. MedReleaf Corp.
14.18. MGC Pharmaceuticals Limited
14.19. Pascal Biosciences Inc.
14.20. PharmaCyte Biotech, Inc.
14.21. Serina Therapeutics, Inc.
14.22. Teva Pharmaceutical Industries Ltd.
14.23. Tilray, Inc.
14.24. Valeant Pharmaceuticals
14.25. Zynerba Pharmaceuticals, Inc.
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL CANNABIS PHARMACEUTICALS MARKET: DYNAMICS
FIGURE 2. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2021 VS 2027 (%)
FIGURE 3. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2021 VS 2027 (USD MILLION)
FIGURE 4. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2027
FIGURE 5. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY EPIDIOLEX, 2019-2027 (USD MILLION)
FIGURE 6. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY EPIDIOLEX, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 7. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY SATIVEX, 2019-2027 (USD MILLION)
FIGURE 8. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY SATIVEX, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 9. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2021 VS 2027 (%)
FIGURE 10. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2021 VS 2027 (USD MILLION)
FIGURE 11. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2027
FIGURE 12. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY OINTMENTS & CREAMS, 2019-2027 (USD MILLION)
FIGURE 13. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY OINTMENTS & CREAMS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 14. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY SOLIDS AND DISSOLVABLE POWDER & OIL, 2019-2027 (USD MILLION)
FIGURE 15. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY SOLIDS AND DISSOLVABLE POWDER & OIL, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 16. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2021 VS 2027 (%)
FIGURE 17. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2021 VS 2027 (USD MILLION)
FIGURE 18. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2027
FIGURE 19. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY HOSPITAL PHARMACIES, 2019-2027 (USD MILLION)
FIGURE 20. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 21. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY ONLINE PHARMACIES, 2019-2027 (USD MILLION)
FIGURE 22. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 23. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY RETAIL PHARMACIES, 2019-2027 (USD MILLION)
FIGURE 24. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 25. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2021 VS 2027 (%)
FIGURE 26. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2021 VS 2027 (USD MILLION)
FIGURE 27. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2027
FIGURE 28. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY ARTHRITIS, 2019-2027 (USD MILLION)
FIGURE 29. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY ARTHRITIS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 30. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY CANCER, 2019-2027 (USD MILLION)
FIGURE 31. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY CANCER, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 32. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY EPILEPSY, 2019-2027 (USD MILLION)
FIGURE 33. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY EPILEPSY, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 34. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY MIGRAINE, 2019-2027 (USD MILLION)
FIGURE 35. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY MIGRAINE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 36. AMERICAS CANNABIS PHARMACEUTICALS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 37. ARGENTINA CANNABIS PHARMACEUTICALS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 38. BRAZIL CANNABIS PHARMACEUTICALS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 39. CANADA CANNABIS PHARMACEUTICALS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 40. MEXICO CANNABIS PHARMACEUTICALS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 41. UNITED STATES CANNABIS PHARMACEUTICALS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 42. ASIA-PACIFIC CANNABIS PHARMACEUTICALS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 43. AUSTRALIA CANNABIS PHARMACEUTICALS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 44. CHINA CANNABIS PHARMACEUTICALS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 45. INDIA CANNABIS PHARMACEUTICALS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 46. INDONESIA CANNABIS PHARMACEUTICALS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 47. JAPAN CANNABIS PHARMACEUTICALS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 48. MALAYSIA CANNABIS PHARMACEUTICALS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 49. PHILIPPINES CANNABIS PHARMACEUTICALS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 50. SINGAPORE CANNABIS PHARMACEUTICALS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 51. SOUTH KOREA CANNABIS PHARMACEUTICALS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 52. TAIWAN CANNABIS PHARMACEUTICALS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 53. THAILAND CANNABIS PHARMACEUTICALS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 54. EUROPE, MIDDLE EAST & AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 55. FRANCE CANNABIS PHARMACEUTICALS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 56. GERMANY CANNABIS PHARMACEUTICALS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 57. ITALY CANNABIS PHARMACEUTICALS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 58. NETHERLANDS CANNABIS PHARMACEUTICALS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 59. QATAR CANNABIS PHARMACEUTICALS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 60. RUSSIA CANNABIS PHARMACEUTICALS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 61. SAUDI ARABIA CANNABIS PHARMACEUTICALS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 62. SOUTH AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 63. SPAIN CANNABIS PHARMACEUTICALS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 64. UNITED ARAB EMIRATES CANNABIS PHARMACEUTICALS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 65. UNITED KINGDOM CANNABIS PHARMACEUTICALS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 66. GLOBAL CANNABIS PHARMACEUTICALS MARKET: FPNV POSITIONING MATRIX
FIGURE 67. GLOBAL CANNABIS PHARMACEUTICALS MARKET: SHARE, BY KEY PLAYER, 2021
FIGURE 68. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL CANNABIS PHARMACEUTICALS MARKET, BY TYPE
List of Tables
TABLE 1. GLOBAL CANNABIS PHARMACEUTICALS MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2019-2027 (USD MILLION)
TABLE 4. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY EPIDIOLEX, BY REGION, 2019-2027 (USD MILLION)
TABLE 5. AMERICAS CANNABIS PHARMACEUTICALS MARKET SIZE, BY EPIDIOLEX, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 6. UNITED STATES CANNABIS PHARMACEUTICALS MARKET SIZE, BY EPIDIOLEX, BY STATE, 2019-2027 (USD MILLION)
TABLE 7. ASIA-PACIFIC CANNABIS PHARMACEUTICALS MARKET SIZE, BY EPIDIOLEX, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 8. EUROPE, MIDDLE EAST & AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY EPIDIOLEX, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 9. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY SATIVEX, BY REGION, 2019-2027 (USD MILLION)
TABLE 10. AMERICAS CANNABIS PHARMACEUTICALS MARKET SIZE, BY SATIVEX, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 11. UNITED STATES CANNABIS PHARMACEUTICALS MARKET SIZE, BY SATIVEX, BY STATE, 2019-2027 (USD MILLION)
TABLE 12. ASIA-PACIFIC CANNABIS PHARMACEUTICALS MARKET SIZE, BY SATIVEX, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 13. EUROPE, MIDDLE EAST & AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY SATIVEX, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 14. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2019-2027 (USD MILLION)
TABLE 15. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY OINTMENTS & CREAMS, BY REGION, 2019-2027 (USD MILLION)
TABLE 16. AMERICAS CANNABIS PHARMACEUTICALS MARKET SIZE, BY OINTMENTS & CREAMS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 17. UNITED STATES CANNABIS PHARMACEUTICALS MARKET SIZE, BY OINTMENTS & CREAMS, BY STATE, 2019-2027 (USD MILLION)
TABLE 18. ASIA-PACIFIC CANNABIS PHARMACEUTICALS MARKET SIZE, BY OINTMENTS & CREAMS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 19. EUROPE, MIDDLE EAST & AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY OINTMENTS & CREAMS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 20. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY SOLIDS AND DISSOLVABLE POWDER & OIL, BY REGION, 2019-2027 (USD MILLION)
TABLE 21. AMERICAS CANNABIS PHARMACEUTICALS MARKET SIZE, BY SOLIDS AND DISSOLVABLE POWDER & OIL, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 22. UNITED STATES CANNABIS PHARMACEUTICALS MARKET SIZE, BY SOLIDS AND DISSOLVABLE POWDER & OIL, BY STATE, 2019-2027 (USD MILLION)
TABLE 23. ASIA-PACIFIC CANNABIS PHARMACEUTICALS MARKET SIZE, BY SOLIDS AND DISSOLVABLE POWDER & OIL, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 24. EUROPE, MIDDLE EAST & AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY SOLIDS AND DISSOLVABLE POWDER & OIL, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 25. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 26. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2019-2027 (USD MILLION)
TABLE 27. AMERICAS CANNABIS PHARMACEUTICALS MARKET SIZE, BY HOSPITAL PHARMACIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 28. UNITED STATES CANNABIS PHARMACEUTICALS MARKET SIZE, BY HOSPITAL PHARMACIES, BY STATE, 2019-2027 (USD MILLION)
TABLE 29. ASIA-PACIFIC CANNABIS PHARMACEUTICALS MARKET SIZE, BY HOSPITAL PHARMACIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 30. EUROPE, MIDDLE EAST & AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY HOSPITAL PHARMACIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 31. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2019-2027 (USD MILLION)
TABLE 32. AMERICAS CANNABIS PHARMACEUTICALS MARKET SIZE, BY ONLINE PHARMACIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 33. UNITED STATES CANNABIS PHARMACEUTICALS MARKET SIZE, BY ONLINE PHARMACIES, BY STATE, 2019-2027 (USD MILLION)
TABLE 34. ASIA-PACIFIC CANNABIS PHARMACEUTICALS MARKET SIZE, BY ONLINE PHARMACIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 35. EUROPE, MIDDLE EAST & AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY ONLINE PHARMACIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 36. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2019-2027 (USD MILLION)
TABLE 37. AMERICAS CANNABIS PHARMACEUTICALS MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 38. UNITED STATES CANNABIS PHARMACEUTICALS MARKET SIZE, BY RETAIL PHARMACIES, BY STATE, 2019-2027 (USD MILLION)
TABLE 39. ASIA-PACIFIC CANNABIS PHARMACEUTICALS MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 40. EUROPE, MIDDLE EAST & AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 41. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 42. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY ARTHRITIS, BY REGION, 2019-2027 (USD MILLION)
TABLE 43. AMERICAS CANNABIS PHARMACEUTICALS MARKET SIZE, BY ARTHRITIS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 44. UNITED STATES CANNABIS PHARMACEUTICALS MARKET SIZE, BY ARTHRITIS, BY STATE, 2019-2027 (USD MILLION)
TABLE 45. ASIA-PACIFIC CANNABIS PHARMACEUTICALS MARKET SIZE, BY ARTHRITIS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 46. EUROPE, MIDDLE EAST & AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY ARTHRITIS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 47. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY CANCER, BY REGION, 2019-2027 (USD MILLION)
TABLE 48. AMERICAS CANNABIS PHARMACEUTICALS MARKET SIZE, BY CANCER, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 49. UNITED STATES CANNABIS PHARMACEUTICALS MARKET SIZE, BY CANCER, BY STATE, 2019-2027 (USD MILLION)
TABLE 50. ASIA-PACIFIC CANNABIS PHARMACEUTICALS MARKET SIZE, BY CANCER, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 51. EUROPE, MIDDLE EAST & AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY CANCER, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 52. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY EPILEPSY, BY REGION, 2019-2027 (USD MILLION)
TABLE 53. AMERICAS CANNABIS PHARMACEUTICALS MARKET SIZE, BY EPILEPSY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 54. UNITED STATES CANNABIS PHARMACEUTICALS MARKET SIZE, BY EPILEPSY, BY STATE, 2019-2027 (USD MILLION)
TABLE 55. ASIA-PACIFIC CANNABIS PHARMACEUTICALS MARKET SIZE, BY EPILEPSY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 56. EUROPE, MIDDLE EAST & AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY EPILEPSY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 57. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY MIGRAINE, BY REGION, 2019-2027 (USD MILLION)
TABLE 58. AMERICAS CANNABIS PHARMACEUTICALS MARKET SIZE, BY MIGRAINE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 59. UNITED STATES CANNABIS PHARMACEUTICALS MARKET SIZE, BY MIGRAINE, BY STATE, 2019-2027 (USD MILLION)
TABLE 60. ASIA-PACIFIC CANNABIS PHARMACEUTICALS MARKET SIZE, BY MIGRAINE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 61. EUROPE, MIDDLE EAST & AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY MIGRAINE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 62. AMERICAS CANNABIS PHARMACEUTICALS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 63. ARGENTINA CANNABIS PHARMACEUTICALS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 64. BRAZIL CANNABIS PHARMACEUTICALS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 65. CANADA CANNABIS PHARMACEUTICALS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 66. MEXICO CANNABIS PHARMACEUTICALS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 67. UNITED STATES CANNABIS PHARMACEUTICALS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 68. ASIA-PACIFIC CANNABIS PHARMACEUTICALS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 69. AUSTRALIA CANNABIS PHARMACEUTICALS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 70. CHINA CANNABIS PHARMACEUTICALS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 71. INDIA CANNABIS PHARMACEUTICALS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 72. INDONESIA CANNABIS PHARMACEUTICALS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 73. JAPAN CANNABIS PHARMACEUTICALS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 74. MALAYSIA CANNABIS PHARMACEUTICALS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 75. PHILIPPINES CANNABIS PHARMACEUTICALS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 76. SINGAPORE CANNABIS PHARMACEUTICALS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 77. SOUTH KOREA CANNABIS PHARMACEUTICALS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 78. TAIWAN CANNABIS PHARMACEUTICALS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 79. THAILAND CANNABIS PHARMACEUTICALS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 81. FRANCE CANNABIS PHARMACEUTICALS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 82. GERMANY CANNABIS PHARMACEUTICALS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 83. ITALY CANNABIS PHARMACEUTICALS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 84. NETHERLANDS CANNABIS PHARMACEUTICALS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 85. QATAR CANNABIS PHARMACEUTICALS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 86. RUSSIA CANNABIS PHARMACEUTICALS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 87. SAUDI ARABIA CANNABIS PHARMACEUTICALS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 88. SOUTH AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 89. SPAIN CANNABIS PHARMACEUTICALS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 90. UNITED ARAB EMIRATES CANNABIS PHARMACEUTICALS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 91. UNITED KINGDOM CANNABIS PHARMACEUTICALS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 92. GLOBAL CANNABIS PHARMACEUTICALS MARKET: SCORES
TABLE 93. GLOBAL CANNABIS PHARMACEUTICALS MARKET: BUSINESS STRATEGY
TABLE 94. GLOBAL CANNABIS PHARMACEUTICALS MARKET: PRODUCT SATISFACTION
TABLE 95. GLOBAL CANNABIS PHARMACEUTICALS MARKET: RANKING
TABLE 96. GLOBAL CANNABIS PHARMACEUTICALS MARKET: SHARE, BY KEY PLAYER, 2021
TABLE 97. GLOBAL CANNABIS PHARMACEUTICALS MARKET: MERGER & ACQUISITION
TABLE 98. GLOBAL CANNABIS PHARMACEUTICALS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 99. GLOBAL CANNABIS PHARMACEUTICALS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 100. GLOBAL CANNABIS PHARMACEUTICALS MARKET: INVESTMENT & FUNDING
TABLE 101. GLOBAL CANNABIS PHARMACEUTICALS MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 102. GLOBAL CANNABIS PHARMACEUTICALS MARKET: LICENSE & PRICING

Companies Mentioned

  • AbbVie Inc.
  • Amyris, Inc.
  • Aphria, Inc.
  • Aurora Cannabis, Inc.
  • Botanix Pharmaceuticals
  • Breath of Life Pharma, Ltd.
  • Cannabis Science, Inc.
  • Canopy Growth Corporation
  • Cara Therapeutics
  • CB Therapeutics Inc.
  • Corbus Pharmaceuticals Holdings, Inc.
  • Cronos Group Inc.
  • GW Pharmaceuticals, PLC
  • Insys Therapeutics, Inc.
  • Medical Marijuana Inc.
  • Medicure Pharmaceuticals
  • MedReleaf Corp.
  • MGC Pharmaceuticals Limited
  • Pascal Biosciences Inc.
  • PharmaCyte Biotech, Inc.
  • Serina Therapeutics, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Tilray, Inc.
  • Valeant Pharmaceuticals
  • Zynerba Pharmaceuticals, Inc.

Methodology

Loading
LOADING...